Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer.
Kathinka S SlørdahlDagmar KlotzJan-Åge OlsenEva SkovlundChristine UndsethHeidi Larsen AbildgaardMorten BrændengenArild NesbakkenStein Gunnar LarsenBettina A HanekampLaila HolmboeRagnhild TvedtAnita SveenRagnhild A LotheEirik MalinenStein KaasaMarianne Grønlie GurenPublished in: Acta oncologica (Stockholm, Sweden) (2021)
State-of-the-art chemoradiotherapy for SCCA resulted in excellent outcomes, and improved survival compared with previous national data, with <15% treatment failures and a 3-year DFS of >80%.